Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Aubreyon Jun 07, 2018 10:56pm
153 Views
Post# 28143767

RE:RE:RE:RE:As a layman

RE:RE:RE:RE:As a laymanlessons learnt...they stoped the trial because they knew all they needed to know,  All I know is aquired by observing evidence..and I see contradictions akin to an episode of the Simpsons. Back in November the market didn't like the trial results...but now  the doctors running the trial stopped it early bescaus they like the results., we know all we need to know, maybe it's just what the doctor ordered. was stated and implied. . ...it's nearly the same data.,so a disconnect between the market and reality. The data reveals a dependble proceedure. The data says the doctors want this to be developed...the sooner the better was implied., the protocol for ph2 will reveal if that translates into action.

So when will we get a peek at the protocol for ph2 ?





























































































































































































































































































































































































































































































































































































Bullboard Posts